We're talking about vaccines and all the issues surrounding vaccines that we're continuing

to discover.

The same thing is happening with the antiviral Pax Lovid.

Now, if we remember in December of last year, 2021, the FDA approved Pax Lovid.

This was the headline from their own website.

You can see the regulatory approval here.

Coronavirus update.

FDA authorizes first oral antiviral for treatment of COVID-19.

Now what's interesting about this is on the back of that story, we know that the year

prior to that, there was an intense battle going on, hydroxychloroquine that come out

of the antiviral.

Right.

And you saw the WHO swoop in, give tons of money for studies where they pack the studies

with-

I mean, let's be clear, we had Ford Medical Center do a powerful study, one of the greatest

research centers in America coming forward and saying, our study shows a 50% reduction

in death amongst those that receive hydroxychloroquine.

That should have been it.

That should have been the story.

And the product hydroxychloroquine is being used all around the world in people who aren't

even in good health that suffer from malaria, no problems there, no problems in all the

other uses that are off label here in the United States of America.

...